Sensus Healthcare Statistics
Total Valuation
SRTS has a market cap or net worth of $64.06 million. The enterprise value is $40.14 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SRTS has 16.43 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 16.43M |
| Shares Outstanding | 16.43M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 17.48% |
| Owned by Institutions (%) | 28.05% |
| Float | 13.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.79 |
| Forward PS | 1.73 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | 29.56 |
| P/OCF Ratio | 33.57 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 18.52 |
Financial Position
The company has a current ratio of 7.38, with a Debt / Equity ratio of 0.01.
| Current Ratio | 7.38 |
| Quick Ratio | 4.97 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.25 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -5.71% and return on invested capital (ROIC) is -6.38%.
| Return on Equity (ROE) | -5.71% |
| Return on Assets (ROA) | -5.75% |
| Return on Invested Capital (ROIC) | -6.38% |
| Return on Capital Employed (ROCE) | -10.55% |
| Revenue Per Employee | $659,426 |
| Profits Per Employee | -$55,667 |
| Employee Count | 54 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.32 |
Taxes
| Income Tax | -1.67M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.86% in the last 52 weeks. The beta is 1.24, so SRTS's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -54.86% |
| 50-Day Moving Average | 3.63 |
| 200-Day Moving Average | 4.21 |
| Relative Strength Index (RSI) | 49.45 |
| Average Volume (20 Days) | 106,376 |
Short Selling Information
The latest short interest is 570,357, so 3.47% of the outstanding shares have been sold short.
| Short Interest | 570,357 |
| Short Previous Month | 588,413 |
| Short % of Shares Out | 3.47% |
| Short % of Float | 4.21% |
| Short Ratio (days to cover) | 3.77 |
Income Statement
In the last 12 months, SRTS had revenue of $35.61 million and -$3.01 million in losses. Loss per share was -$0.18.
| Revenue | 35.61M |
| Gross Profit | 17.08M |
| Operating Income | -5.43M |
| Pretax Income | -4.68M |
| Net Income | -3.01M |
| EBITDA | -5.07M |
| EBIT | -5.43M |
| Loss Per Share | -$0.18 |
Full Income StatementBalance Sheet
The company has $24.45 million in cash and $534,000 in debt, giving a net cash position of $23.92 million or $1.46 per share.
| Cash & Cash Equivalents | 24.45M |
| Total Debt | 534,000 |
| Net Cash | 23.92M |
| Net Cash Per Share | $1.46 |
| Equity (Book Value) | 51.19M |
| Book Value Per Share | 3.11 |
| Working Capital | 43.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.91 million and capital expenditures $259,000, giving a free cash flow of $2.17 million.
| Operating Cash Flow | 1.91M |
| Capital Expenditures | 259,000 |
| Free Cash Flow | 2.17M |
| FCF Per Share | $0.13 |
Full Cash Flow StatementMargins
Gross margin is 47.95%, with operating and profit margins of -15.26% and -8.44%.
| Gross Margin | 47.95% |
| Operating Margin | -15.26% |
| Pretax Margin | -13.13% |
| Profit Margin | -8.44% |
| EBITDA Margin | -14.22% |
| EBIT Margin | -15.26% |
| FCF Margin | 6.09% |
Dividends & Yields
SRTS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | -4.69% |
| FCF Yield | 3.38% |
Analyst Forecast
The average price target for SRTS is $8.00, which is 105.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 105.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SRTS has an Altman Z-Score of 8.96 and a Piotroski F-Score of 2.
| Altman Z-Score | 8.96 |
| Piotroski F-Score | 2 |